CUSIP: G6855A103
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
22,923,370
-
Share change
-
+2,711,089
-
Total reported value
-
$385,118,397
-
Price per share
-
$16.80
-
Number of holders
-
79
-
Value change
-
+$45,549,310
-
Number of buys
-
35
-
Number of sells
-
36
Quarterly Holders Quick Answers
What is CUSIP G6855A103?
CUSIP G6855A103 identifies OXFD - OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP G6855A103:
Institutional Holders of OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) as of Q3 2017
As of 30 Sep 2017,
OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,923,370 shares.
The largest 10 holders included
Invesco Ltd., Polar Capital LLP, Redmile Group, LLC, Alyeska Investment Group, L.P., RTW INVESTMENTS, LP, BlackRock Inc., DEERFIELD MANAGEMENT CO, AXA, New Leaf Venture Partners, L.L.C., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
79
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.